Freemont Management S.A. Biomarin Pharmaceutical Inc Transaction History
Freemont Management S.A.
- $647 Million
- Q1 2024
A detailed history of Freemont Management S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Freemont Management S.A. holds 50,900 shares of BMRN stock, worth $4.21 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
50,900
Previous 66,700
23.69%
Holding current value
$4.21 Million
Previous $6.43 Million
30.88%
% of portfolio
0.69%
Previous 0.86%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.55 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.5 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.2 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.16 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$570 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...